Retavase

Active Ingredient(s): Reteplase, r-PA
FDA Approved: * October 30, 1996
Pharm Company: * CENTOCOR INC
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Retavase Overview

Reteplase, trade names Retavase among others, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them. Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein. It is produced in the bacterium Escherichia coli.[citation needed] Reteplase is similar to recombinant human tissue plasminogen activator (alteplase), but the modific...

Read more Retavase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Reteplase

Recent Retavase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Reteplase, r-PA
  • Injection: 10unit
  • Vial: 18.8mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Retavase: (4 results)

Sorted by National Drug Code
  • 10122-141 Retavase Kit by Chiesi USA, Inc.
  • 10122-143 Retavase Kit by Chiesi USA, Inc.
  • 24477-040 Retavase Kit by Ekr Therapeutics, Inc.
  • 24477-041 Retavase Kit by Ekr Therapeutics, Inc.

Other drugs which contain Reteplase, r-PA or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA